Sensitivity of dopaminergic neuron differentiation from stem cells to chronic low-dose methylmercury exposure.

Perinatal exposure to low doses of methylmercury (MeHg) can cause adult neurological symptoms. Rather than leading to a net cell loss, the toxicant is assumed to alter the differentiation and neuronal functions such as catecholaminergic transmission. We used neuronally differentiating murine embryonic stem cells (mESC) to explore such subtle toxicity. The mixed neuronal cultures that formed within 20 days contained a small subpopulation of tyrosine hydroxylase (TH)-positive neurons with specific dopaminergic functions such as dopamine transport (DAT) activity. The last 6 days of differentiation were associated with the functional maturation of already preformed neuronal precursors. Exposure to MeHg during this period downregulated several neuronal transcripts, without affecting housekeeping genes or causing measurable cell loss. Profiling of mRNAs relevant for neurotransmitter systems showed that dopamine receptors were coordinately downregulated, whereas known counterregulatory systems such as galanin receptor 2 were upregulated. The chronic (6 days) exposure to MeHg, but not shorter incubation periods, attenuated the expression levels of endogenous neurotrophic factors required for the maturation of TH cells. Accordingly, the size of this cell population was diminished, and DAT activity as its signature function was lost. When mixed lineage kinase activity was blocked during MeHg exposure, DAT activity was restored, and the reduction of TH levels was prevented. Thus, transcriptional profiling in differentiating mESC identified a subpopulation of neurons affected by MeHg, and a pharmacological intervention was identified that specifically protected these cells.

[1]  P. Landrigan,et al.  Developmental neurotoxicity of industrial chemicals , 2006, The Lancet.

[2]  T. Hartung,et al.  Gene expression as a sensitive endpoint to evaluate cell differentiation and maturation of the developing central nervous system in primary cultures of rat cerebellar granule cells (CGCs) exposed to pesticides. , 2009, Toxicology and applied pharmacology.

[3]  J. S. Woods,et al.  Up-regulation of glutathione synthesis in rat kidney by methyl mercury. Relationship to mercury-induced oxidative stress. , 1995, Biochemical pharmacology.

[4]  M. Didriksen,et al.  Nest building performance following MPTP toxicity in mice , 2010, Behavioural Brain Research.

[5]  B. Weiss,et al.  Methylmercury developmental neurotoxicity: a comparison of effects in humans and animals. , 1990, Neurotoxicology and teratology.

[6]  M. Leist,et al.  Requirement of a dopaminergic neuronal phenotype for toxicity of low concentrations of 1-methyl-4-phenylpyridinium to human cells. , 2009, Toxicology and applied pharmacology.

[7]  B. Kofler,et al.  The galanin peptide family: receptor pharmacology, pleiotropic biological actions, and implications in health and disease. , 2007, Pharmacology & therapeutics.

[8]  M. Bencherif Neuronal nicotinic receptors as novel targets for inflammation and neuroprotection: mechanistic considerations and clinical relevance , 2009, Acta Pharmacologica Sinica.

[9]  W. Koh,et al.  Coordinated waves of gene expression during neuronal differentiation of embryonic stem cells as basis for novel approaches to developmental neurotoxicity testing , 2011, Cell Death and Differentiation.

[10]  D. Wynick,et al.  Activation of the galanin receptor 2 (GalR2) protects the hippocampus from neuronal damage , 2007, Journal of neurochemistry.

[11]  M. C. Newland,et al.  Aging unmasks adverse effects of gestational exposure to methylmercury in rats. , 2000, Neurotoxicology and teratology.

[12]  Tanja Waldmann,et al.  Markers of murine embryonic and neural stem cells, neurons and astrocytes: reference points for developmental neurotoxicity testing. , 2010, ALTEX.

[13]  B. Weiss,et al.  Silent latency periods in methylmercury poisoning and in neurodegenerative disease. , 2002, Environmental health perspectives.

[14]  Kevin M Crofton,et al.  Comparison of PC12 and cerebellar granule cell cultures for evaluating neurite outgrowth using high content analysis. , 2010, Neurotoxicology and teratology.

[15]  S. Ceccatelli,et al.  Prenatal exposure to methylmercury changes dopamine-modulated motor activity during early ontogeny: age and gender-dependent effects. , 2001, Environmental toxicology and pharmacology.

[16]  M. Aschner,et al.  Methylmercury induces acute oxidative stress, altering Nrf2 protein level in primary microglial cells. , 2010, Toxicological sciences : an official journal of the Society of Toxicology.

[17]  Austin G Smith,et al.  Defined conditions for neural commitment and differentiation. , 2003, Methods in enzymology.

[18]  M. Leist,et al.  Improvement of embryonic dopaminergic neurone survival in culture and after grafting into the striatum of hemiparkinsonian rats by CEP‐1347 , 2003, Journal of neurochemistry.

[19]  Thomas Dino Rockel,et al.  Human Neurospheres as Three-Dimensional Cellular Systems for Developmental Neurotoxicity Testing , 2009, Environmental health perspectives.

[20]  P. Brundin,et al.  Tyrosine hydroxylase expression is unstable in a human immortalized mesencephalic cell line—Studies in vitro and after intracerebral grafting in vivo , 2007, Molecular and Cellular Neuroscience.

[21]  M. Dennis,et al.  Developmental neurobiology , 1971, Neurology.

[22]  Philip J. Landrigan,et al.  Early Environmental Origins of Neurodegenerative Disease in Later Life , 2005, Environmental health perspectives.

[23]  A. Wendroff The toxicology of mercury. , 2004, The New England journal of medicine.

[24]  M. Aschner,et al.  Effects of methylmercury on primary brain cells in mono- and co-culture. , 2005, Toxicological sciences : an official journal of the Society of Toxicology.

[25]  Hedi Peterson,et al.  g:Profiler—a web-based toolset for functional profiling of gene lists from large-scale experiments , 2007, Nucleic Acids Res..

[26]  S. Ceccatelli,et al.  Neurodevelopmental toxicity of methylmercury: Laboratory animal data and their contribution to human risk assessment. , 2008, Regulatory toxicology and pharmacology : RTP.

[27]  R. Kavlock,et al.  Effects of neonatal methylmercury exposure n development of nucleic acids and proteins in rat brain: Regional specificity , 1985, Brain Research Bulletin.

[28]  T. Hökfelt,et al.  Effects of prenatal exposure to methylmercury on dopamine-mediated locomotor activity and dopamine D2 receptor binding , 2003, Naunyn-Schmiedeberg's Archives of Pharmacology.

[29]  F. Doré,et al.  Neurobehavioral changes in mice chronically exposed to methylmercury during fetal and early postnatal development. , 2003, Neurotoxicology and teratology.

[30]  J. Langston,et al.  Astrocytes as the site for bioactivation of neurotoxins. , 1996, Neurotoxicology.

[31]  O. Hermanson,et al.  Methylmercury inhibits differentiation of rat neural stem cells via Notch signalling , 2008, Neuroreport.

[32]  S. Ceccatelli,et al.  Prenatal exposure to methylmercury alters locomotor activity of male but not female rats , 1997, Experimental Brain Research.

[33]  B. Rajanna,et al.  Influence of mercury on uptake of [3H]dopamine and [3H]norepinephrine by rat brain synaptosomes. , 1985, Toxicology letters.

[34]  S. Ceccatelli,et al.  Neurobehavioural and molecular changes induced by methylmercury exposure during development , 2007, Neurotoxicity Research.

[35]  T. Hökfelt,et al.  Developmental exposure to methylmercury alters learning and induces depression-like behavior in male mice. , 2007, Toxicological sciences : an official journal of the Society of Toxicology.

[36]  A. Eisen,et al.  ALZHEIMER'S DISEASE, PARKINSON'S DISEASE, AND MOTONEURONE DISEASE: ABIOTROPIC INTERACTION BETWEEN AGEING AND ENVIRONMENT? , 1986, The Lancet.

[37]  T. Hartung,et al.  mRNA expression is a relevant tool to identify developmental neurotoxicants using an in vitro approach. , 2010, Toxicological sciences : an official journal of the Society of Toxicology.

[38]  P. Vanderhaeghen,et al.  Mechanisms of neural specification from embryonic stem cells , 2010, Current Opinion in Neurobiology.

[39]  A. Takashima,et al.  Methylmercury induces neuropathological changes with tau hyperphosphorylation mainly through the activation of the c-jun-N-terminal kinase pathway in the cerebral cortex, but not in the hippocampus of the mouse brain. , 2009, Neurotoxicology.